(Bloomberg) -- Dr. Reddy's Laboratories Ltd.,
India's biggest drugmaker, is developing eight generic medicines
using biotechnology and plans to release one for sale a year,
challenging companies such as Roche Holding NV and Amgen Inc.
Reddy's may double the number of people in its biotech
division to about 340 in the next two years and plans to spend
about $20 million bolstering production capacity there, Chief
Executive Officer G.V. Prasad said yesterday.
Read more at Bloomberg Emerging Markets News
India's biggest drugmaker, is developing eight generic medicines
using biotechnology and plans to release one for sale a year,
challenging companies such as Roche Holding NV and Amgen Inc.
Reddy's may double the number of people in its biotech
division to about 340 in the next two years and plans to spend
about $20 million bolstering production capacity there, Chief
Executive Officer G.V. Prasad said yesterday.
Read more at Bloomberg Emerging Markets News
No comments:
Post a Comment